This public procurement contract involves the ongoing supply of medicinal products containing ivacaftor, tezacaftor, and elexacaftor until April 11, 2027, and medicinal products containing ivacaftor until December 17, 2028, according to the current needs of the contracting authority.
Contract awarded. Originally published 5 months ago.
This public procurement contract involves the ongoing supply of medications containing palopegteriparatide for a duration of 4 years, based on the current needs of the contracting authority. The total value of the contract is 79,200,000 CZK. Suppliers are invited to provide these essential health pr
This public procurement contract involves the construction of a new standalone building for the Hradec Králové Hospital, specifically designed for the Infectious Diseases Clinic and the Dermatology Clinic. The project includes the relocation of utility networks, construction of ground, transport, an
This public procurement contract involves the ongoing supply, installation, and configuration of blade server technology, including necessary accessories, as well as the provision of technical and post-warranty support. Additionally, the contract includes the installation of software defined by the
This public procurement contract involves the ongoing supply of medicinal products containing povidone-iodine (ATC D08AG02) for a duration of 4 years, based on the current needs of the contracting authority. The total value of the contract is approximately 2,362,662.60 EUR. Suppliers are invited to
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
